Zai Lab’s $230 Million Shares Offering


Simpson Thacher represented the underwriters in connection with the $230 million equity offering by Zai Lab.

Zai Lab Limited (“Zai Lab”) offered 9,019,608 American depositary shares (“ADSs”), each representing one ordinary share of Zai Lab, at a public offering price of $25.50 per ADS. Zai Lab received approximately $216 million in net proceeds from the offering.

J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Jefferies LLC and SVB Leerink LLC acted as underwriters in the deal.

Zai Lab is a China and U.S.-based innovative commercial stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world.

The Simpson Thacher team for the transaction included Art Robinson (Picture), Hui Lin, John O’Connell, and Tracy Peng (Capital Markets); Vanessa Burrows (Healthcare); Robert Holo and Tyler Robbins (Tax); Ashlie Lawton (Benefits); Michael Isby (Environmental); Lori Lesser and Alysha Sekhon (IP); and Jennie Getsin and Andrew Pagliughi (Blue Sky/FINRA).

Involved fees earner: Vanessa Burrows – Simpson Thacher & Bartlett; Jennie Getsin – Simpson Thacher & Bartlett; Robert Holo – Simpson Thacher & Bartlett; Michael Isby – Simpson Thacher & Bartlett; Ashlie Lawton – Simpson Thacher & Bartlett; Lori Lesser – Simpson Thacher & Bartlett; Hui Lin – Simpson Thacher & Bartlett; John O’Connell – Simpson Thacher & Bartlett; Andrew Pagliughi – Simpson Thacher & Bartlett; Tengteng Tracy Peng – Simpson Thacher & Bartlett; Tyler Robbins – Simpson Thacher & Bartlett; Arthur Robinson – Simpson Thacher & Bartlett; Alysha Sekhon – Simpson Thacher & Bartlett;

Law Firms: Simpson Thacher & Bartlett;

Clients: Citigroup Global Markets Ltd; J.P. Morgan Securities LLC; Jefferies; SVB Leerink LLC;